CLINICAL SIGNS OF CHEMOTHERAPY-INDUCED NEUROPATHY IN CANCER PATIENTS AND PHARMACOTHERAPY CORRECTION OPTIONS
The study objective was to analyze the clinical signs of chemotherapy-induced neuropathy (CIPN) in cancer patients and explore pharmacotherapy correction options using vitamin B. Materials and design. During Part 1 lasting from May to September 2017, we screened and then enrolled 219 consecutive pat...
Saved in:
| Main Authors: | I. A. Zolotovskayaia, I. L. Davydkin, T. M. Lokshtanova, A. E. Orlov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2018-03-01
|
| Series: | Архивъ внутренней медицины |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/771 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current understanding of chemotherapy-induced peripheral neuropathy (literature review)
by: O. A. Tikhonova, et al.
Published: (2023-03-01) -
Electrophysiological Markers of Chemotherapy-Induced Polyneuropathy
by: Olga A. Tikhonova, et al.
Published: (2025-06-01) -
Neuroinflammation and сhemotherapy-induced peripheral neuropathy
by: P. I. Pilipenko, et al.
Published: (2022-04-01) -
Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS)
by: Wolfgang Boehmerle, et al.
Published: (2025-04-01) -
Exercise, quality of life and chemotherapy-induced peripheral neuropathy in cancer patients and survivors
by: Joana G. Mateus, et al.
Published: (2025-04-01)